Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing
APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma
Who this might be right for
Melanoma
Aprea Therapeutics 3
Showing 20 of 0 results